Hemodynamic Characteristics and Progression to Heart Failure in Regurgitant Lesions

Heart Failure Clinics

Volumn 2, Issue 4, 2006, Pages 453-460

  Rigolin, Vera H ^a   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REGURGITATION; BETA ADRENERGIC STIMULATION; HEART FAILURE; HEART HEMODYNAMICS; HEART VENTRICLE OVERLOAD; HEART VOLUME; HUMAN; MITRAL VALVE REGURGITATION; REVIEW;

AORTIC VALVE INSUFFICIENCY; CARDIAC VOLUME; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MITRAL VALVE INSUFFICIENCY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247158591     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.09.009     Document Type: Review

References (47)

1. Otto C.M. Evaluation and management of chronic mitral regurgitation. N Engl J Med 345 (2001) 740-746
2. Carabello B.A. Mitral valve regurgitation. Curr Probl Cardiol 23 4 (1998) 200-241
3. Levine R.A. Dynamic mitral regurgitation-more than meets the eye. N Engl J Med 351 (2004) 1681-1684
4. Levine R.A., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005) 745-758
5. Carabello B.A. Progress in mitral and aortic regurgitation. Prog Cardiovasc Dis 43 (2001) 457-475
6. Imamura T., McDermott P.J., Kent R.L., et al. Acute changes in myosin heavy chain synthesis rate in pressure vs volume overload. Circ Res 75 (1994) 418-425
7. Matsuo T., Carabello B.A., Nagatomo Y., et al. Mechanisms of cardiac hypertrophy in canine volume overload. Am J Physiol 275 (1998) H65-H74
8. Mulieri L.A., Leavitt B.J., Ittleman F.P., et al. Forskolin reverses the force-frequency defect in left ventricular subepicardium and (EPI) but not in papillary myocardium in mitral regurgitation heart failure. Circulation 88 Suppl 1 (1993) 406 [abstract]
9. Spinale F.G., Ishihara K., Zile M., et al. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. J Thorac Cardioavsc Surg 106 (1993) 1147-1157
10. Urabe Y., Mann D.L., Kent R.L., et al. Cellular and ventricular dysfunction in experimental canine mitral regurgitation. Circ Res 70 1 (1992) 131-147
11. Mulieri L.A., Leavitt B.J., Martin B.J., et al. Myocardial force frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 88 (1998) 2700-2704
12. Mehta R.H., Supiano M.A., Grossman P.A., et al. Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation. Am Heart J 147 (2004) 729-735
13. Mehta R.H., Supiano M.A., Oral H., et al. Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J 145 (2003) 1078-1085
14. Tsutsui H, Spinale FG, Nagatsu M, et al. Effects of chronic B-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 1994;93(6):2639-48.
15. Starling M.R. Is prophylactic beta-adrenergic blockade appropriate in mitral regurgitation: impact of cellular pathophysiology. Adv Cardiol 41 (2004) 25-35
16. Nemoto S., Hamawaki M., De Freitas G., et al. Differential effects of angiotensin converting enzyme inhibitor lisinopril versus the β-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 40 1 (2002) 149-154
17. Nakano K., Swindle M.M., Spinale F., et al. Depressed contractile function due to canine mitral regurgitation improves after correction of volume overload. J Clin Invest 87 (1991) 2077-2086
18. Ishihara K., Zile M.R., Kanazawa S., et al. Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus. Circulation 86 Suppl II (1992) 16-25
19. Starling M.R. Effects of valve surgery on left ventricular contractile function in patients with long term mitral regurgitation. Circulation 92 (1995) 811-818
20. Robbins J.D., Maniar P.B., Cotts W., et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91 (2003) 360-362
21. Trichon B.H., Felker G.M., Shaw L.K., et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003) 538-543
22. Koelling T.M., Aaronson K.D., Cody R.J., et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144 (2002) 524-529
23. Grayburn P.A., Appleton C.P., DeMaria A.N., et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 45 (2005) 1064-1071
24. Grigioni F., Enriquez-Sarano M., Zehr K.R., et al. Ischemic mitral regurgitation: long term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
25. Bursi F., Enriquez-Sarano M., Vuyisile T.N., et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111 (2005) 295-301
26. Kono T., Sabbah H.N., Rosman H., et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 20 (1992) 1594-1598
27. Sabbah H.N., Rosman H., Kono T., et al. On the mechanism of functional mitral regurgitation. Am J Cardiol 72 (1993) 1074-1076
28. Karagiannis S.E., Karatasakis G.T., Koutsogiannis N., et al. Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure. Heart 89 (2003) 1174-1178
29. Nielsen S.L., Nygaard H., Mandrup L., et al. Mechanism of incomplete mitral leaflet coaptation-interaction of chordal restraint and changes in mitral leaflet coaptation geometry. Insight from in vitro validation of the premise of force equilibrium. J Biomech Eng 124 (2002) 596-608
30. Capomolla S., Febo O., Gnemmi M., et al. β-Blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 139 (2000) 596-608
31. St. John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
32. Breithardt O.A., Sinha A.M., Schwammenthal E., et al. Acute effects if cardiac resynchronization therapy on functional mitral regurgitation in advanced heart failure. J Am Coll Cardiol 41 (2003) 765-770
33. Lancellotti P., Gerard P.L., and Pierard L.A. Long term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26 (2005) 1528-1532
34. Guy T.S., Moaini S.L., Gorman J.H., et al. Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol 43 (2004) 377-383
35. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists; endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 5 (2006) e84-e231
36. Roberts W.C., Ko J.M., Moore T.R., et al. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 114 (2006) 422-429
37. Nistri S., Sorbo M.D., Marin M., et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82 (1999) 19-22
38. Keane M.G., Wiegers S.E., Plappert T., et al. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation 102 (2000) III35-III39
39. Braverman A.C., Guven H., Beardslee M.A., et al. The bicuspid aortic valve. Curr Probl Cardiol 30 (2005) 470-522
40. Bonow R.O. Aortic regurgitation. In: Zipes D. (Ed). Braunwald's heart disease: a textbook of cardiovascular medicine. Valvular heart disease, vol. 2. 7th edition (2005), WB Saunders, Philadelphia 1553-1632
41. Bonow R.O. Chronic aortic regurgitation. Cardiol Clin 16 3 (1998) 449-461
42. Nitenberg A., Foult J.M., Antony I., et al. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am Coll Cardiol 11 (1988) 478-486
43. Bonow R.O. Radionuclide angiography in the management of aortic regurgitation. Circulation 84 Suppl I (1991) I296-I302
44. Borer J.S., Truter S., Herrold E.M., et al. Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105 (2002) 1837-1842
45. Gupta A., Carter J.N., Truter S.L., et al. Cellular response of human cardiac fibroblasts to mechanically stimulated aortic regurgitation. Am J Ther 13 (2006) 8-11
46. Devlin W.H., Petrusha J., Briesmiester B.S., et al. Impact of vascular adaptation to chronic aortic regurgitation on left ventricular performance. Circulation 99 (1999) 1027-1033
47. Borer J.S., and Bonow R.O. Contemporary approach to aortic and mitral regurgitation. Circulation 108 (2003) 2432-2438